Letter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).

scientific article published on 15 February 2013

Letter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4093/DMJ.2013.37.1.81
P932PMC publication ID3579156
P698PubMed publication ID23441299
P5875ResearchGate publication ID235730853

P2093author name stringSheyu Li
Haoming Tian
P2860cites workSecondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialQ29619886
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.Q34628009
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control studyQ36001145
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort studyQ36013549
The risk of bladder cancer in korean diabetic subjects treated with pioglitazone.Q36365241
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue1
P304page(s)81-82
P577publication date2013-02-15
P1433published inDiabetes & metabolism journalQ26842420
P1476titleLetter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).
P478volume37

Reverse relations

Q38641190Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and futurecites workP2860

Search more.